PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
28.38%
Similar revenue growth to VET's 28.88%. Walter Schloss would investigate if similar growth reflects similar quality.
15.95%
Cost growth 50-75% of VET's 28.31%. Bruce Berkowitz would examine sustainable cost advantages.
46.50%
Gross profit growth exceeding 1.5x VET's 29.31%. David Dodd would verify competitive advantages.
14.11%
Margin expansion exceeding 1.5x VET's 0.34%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-9.70%
G&A reduction while VET shows 2.45% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-101.20%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-9.50%
Operating expenses reduction while VET shows 15.39% growth. Joel Greenblatt would examine advantage.
4.00%
Total costs growth less than half of VET's 22.83%. David Dodd would verify sustainability.
13.58%
Interest expense growth less than half of VET's 28.95%. David Dodd would verify sustainability.
16.33%
Similar D&A growth to VET's 18.78%. Walter Schloss would investigate industry patterns.
183.33%
EBITDA growth exceeding 1.5x VET's 47.69%. David Dodd would verify competitive advantages.
66.64%
EBITDA margin growth exceeding 1.5x VET's 1.25%. David Dodd would verify competitive advantages.
202.59%
Operating income growth exceeding 1.5x VET's 47.52%. David Dodd would verify competitive advantages.
179.91%
Operating margin growth exceeding 1.5x VET's 14.47%. David Dodd would verify competitive advantages.
29.52%
Other expenses growth above 1.5x VET's 4.28%. Michael Burry would check for concerning trends.
120.36%
Pre-tax income growth exceeding 1.5x VET's 75.65%. David Dodd would verify competitive advantages.
115.86%
Pre-tax margin growth 1.25-1.5x VET's 81.10%. Bruce Berkowitz would examine sustainability.
108.57%
Tax expense growth 1.25-1.5x VET's 80.93%. Martin Whitman would scrutinize strategy.
125.83%
Net income growth exceeding 1.5x VET's 74.93%. David Dodd would verify competitive advantages.
120.12%
Net margin growth 1.25-1.5x VET's 80.55%. Bruce Berkowitz would examine sustainability.
125.00%
EPS growth exceeding 1.5x VET's 77.78%. David Dodd would verify competitive advantages.
125.32%
Diluted EPS growth exceeding 1.5x VET's 77.98%. David Dodd would verify competitive advantages.
1.20%
Share count reduction exceeding 1.5x VET's 13.19%. David Dodd would verify capital allocation.
-0.51%
Diluted share reduction while VET shows 13.25% change. Joel Greenblatt would examine strategy.